GGrantIndex
Sort

40,608 grants matching prostate cancer

Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer

$333,575
Nima Sharifi · University Of Miami School Of Medicine · R01 · FY2024 · CA

Mechanisms promoting translocations and mature B cell lymphomas

$333,570
Jing Hong Wang · University Of Colorado Denver · R01 · FY2016 · CA

Chemistry and Spectroscopy of Copper Monooxygenases

$333,507
Ninian J Blackburn · Oregon Health & Science University · R01 · FY2010 · NS

Telomeres, telomerase and chemotherapy: Bench to bedside

$333,500
Jessie L.-S. Au · Optimum Therapeutics, Llc · R01 · FY2012 · CA

Endothelial-to-osteoblast transition in prostate cancer bone metastasis

$333,500
Sue-Hwa Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE

$333,487
University Of North Carolina Chapel Hill · P01 · FY2003 · CA

Secretory Phospholipases sPLA2 and their Receptors for Delivering Nanoparticles

$333,485
Robert D Arnold · Auburn University At Auburn · R01 · FY2016 · EB

Phase III Study of Donepezil in the Irradiated Brain

$333,474
Stephen R Rapp · Wake Forest University Health Sciences · R01 · FY2009 · NR

ANDROGEN INDEPENDENT PROSTATE CANCER--A TRANSGENIC MODEL

$333,430
Baylor College Of Medicine · R01 · FY2001 · CA

GENE-ENVIRONMENT INTERACTION IN PROSTATE CANCER

$333,400
Henry Ford Health System · R01 · FY2000 · ES

Project 2: Arsenic as an Endocrine Disruptor

$333,372
Joshua W Hamilton · Dartmouth College · P42 · FY2008 · ES

Targeting Nanoparticle DNA Delivery to Prostate Tumors

$333,365
Janet A. Sawicki · Lankenau Institute For Medical Research · R01 · FY2010 · CA

Targeted Death of Prostatic Cancer Cells

$333,345
Lankenau Institute For Medical Research · R01 · FY2005 · CA

Inhibition of novel molecular targets of prostaglandin formation for antitumor ac

$333,334
Emmanuelle Joelle Meuillet · University Of Arizona · R01 · FY2012 · CA

The Molecular Profile of Prostate Tumors in African-American Men

$333,319
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$333,233
Selina M Luger · University Of Pennsylvania · U10 · FY2013 · CA

Discovery and mechanism of BK channel gating modulators

$333,229
Brad S Rothberg · Temple Univ Of The Commonwealth · R01 · FY2018 · GM

SOUTHWEST ONCOLOGY GROUP

$333,200
University Of Southern California · U10 · FY2002 · CA

Cancer and Leukemia Group B

$333,194
Eric P Winer · Dana-Farber Cancer Inst · U10 · FY2007 · CA

Clinical and Analytical Validation of Cancer Biomarkers

$333,159
Daniel W Chan · Johns Hopkins University · U24 · FY2019 · CA

Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer

$333,149
James F. Rusling · University Of Connecticut Storrs · R01 · FY2015 · EB

MiR-183-96-182 cluster, prostatic zinc homeostasis and carcinogenesis

$333,132
Larisa Nonn · University Of Illinois At Chicago · R01 · FY2013 · CA

The impact of LINE-1 retrotransposons on life span, SASP, and telomeres in vivo

$333,117
Victoria Perepelitsa Belancio · Tulane University Of Louisiana · R01 · FY2019 · AG

Therapeutic Targeting of Wnt Signaling

$333,110
Dianqing Wu · Yale University · R01 · FY2012 · CA

Therapeutic Targeting of Wnt Signaling

$333,110
Dianqing Wu · Yale University · R01 · FY2011 · CA